|
SF3B3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.378300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.003400E-01 |
| Normal-vs-Stage2 |
3.002200E-01 |
| Normal-vs-Stage3 |
1.109570E-02 |
| Normal-vs-Stage4 |
5.188400E-01 |
| Stage1-vs-Stage2 |
6.292600E-01 |
| Stage1-vs-Stage3 |
4.073800E-02 |
| Stage1-vs-Stage4 |
9.374800E-01 |
| Stage2-vs-Stage3 |
2.084000E-01 |
| Stage2-vs-Stage4 |
8.068600E-01 |
| Stage3-vs-Stage4 |
2.229000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.823440E-03 |
| Normal-vs-AfricanAmerican |
5.768600E-01 |
| Normal-vs-Asian |
4.354400E-01 |
| Caucasian-vs-AfricanAmerican |
5.022500E-02 |
| Caucasian-vs-Asian |
7.275000E-01 |
| AfricanAmerican-vs-Asian |
5.060200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.375900E-02 |
| Normal-vs-Female |
1.564190E-04 |
| Male-vs-Female |
5.937000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.015400E-01 |
| Normal-vs-Extreme_Weight |
4.468000E-01 |
| Normal-vs-Obese |
1.622330E-03 |
| Normal-vs-Extreme_Obese |
9.201000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.369800E-01 |
| Normal_Weight-vs-Obese |
2.841900E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.719800E-01 |
| Extreme_Weight-vs-Obese |
1.561580E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.757800E-01 |
| Obese-vs-Extreme_Obese |
1.407450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.632100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.701500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.005580E-01 |
| Normal-vs-Age(81-100Yrs) |
2.817200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.249000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.866100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.193800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.343240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.520900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.000400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.685600E-02 |
| Normal-VS-Type2 PRCC |
4.369800E-01 |
| Normal-VS-KIRP CIMP |
8.077500E-03 |
| Normal-VS-Unclassified PRCC |
1.904600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.209000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.965500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.200000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.364600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.149820E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.985000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.736400E-01 |
| Normal-vs-N1 |
4.376600E-03 |
| Normal-vs-N2 |
6.067000E-01 |
| N0-vs-N1 |
5.996200E-02 |
| N0-vs-N2 |
8.521000E-01 |
| N1-vs-N2 |
4.319400E-01 |
|
|
